Development and Characterization of Amphotericin B Loaded Solid Lipid Nanoparticles Against Experimental Visceral Leishmaniasis

By  

Pharmaceutical Nanotechnology, Vol. 1, Iss. 1, 2013-01 ,pp. : 54-67

Bentham Science Publishers

Access to resources Recommend Favorite

Development and characterization of amphotericin B bearing emulsomes for passive and active macrophage targeting

By Gupta Swati   Vyas Suresh  

Journal of Drug Targeting, Vol. 15, Iss. 3, 2007-04 ,pp. : 206-217

Informa Healthcare

Access to resources Recommend Favorite

Amphotericin B Lipid Complex: In Visceral Leishmaniasis

By Goldsmith David R.   Perry Caroline M.  

Drugs, Vol. 64, Iss. 17, 2004-01 ,pp. : 1905-1911

Adis International

Access to resources Recommend Favorite

Liposomal Amphotericin B: Therapeutic Use in the Management of Fungal Infections and Visceral Leishmaniasis

By Coukell A.J.   Brogden R.N.  

Drugs, Vol. 55, Iss. 4, 1998-04 ,pp. : 585-612

Adis International

Access to resources Recommend Favorite

Superior Chemotherapeutic Efficacy of Amphotericin B in Tuftsin-bearing Liposomes against Leishmania Donovani Infection in Hamsters

By Agrawal Ajay K.   Agrawal A.   Pal A.   Guru P.Y.   Gupta C.M.  

Journal of Drug Targeting, Vol. 10, Iss. 1, 2002-01 ,pp. : 41-45

Informa Healthcare

Access to resources Recommend Favorite